PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.18%
Both yoy net incomes decline, with BTE at -199.57%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
8.81%
D&A growth well above BTE's 16.75%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
1521.43%
Well above BTE's 20.64% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
303.33%
SBC growth while BTE is negative at -55.86%. John Neff would see competitor possibly controlling share issuance more tightly.
175.97%
Well above BTE's 122.31% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-203.03%
AR is negative yoy while BTE is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
181.48%
Growth well above BTE's 122.31%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
332.00%
Well above BTE's 13.16%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
63.76%
Operating cash flow growth above 1.5x BTE's 10.92%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-13.98%
Negative yoy CapEx while BTE is 26.77%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
678.75%
Less M&A spending yoy vs. BTE's 2378.67%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
13.98%
Purchases growth of 13.98% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-41.67%
We reduce yoy sales while BTE is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-13.98%
We reduce yoy other investing while BTE is 164.72%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
152.73%
Investing outflow well above BTE's 51.07%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
12.50%
We repay more while BTE is negative at -519.28%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.